Cargando…

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease

BACKGROUND AND AIM: Toxic oligomeric α-synuclein (αS; O-αS) has been suggested to play a central role in the pathogenesis of Lewy body diseases such as Parkinson’s disease (PD). Cerebrospinal fluid (CSF) levels of αS, O-αS, total and phosphorylated tau, and amyloid β 1–42 (Aβ1–42) are thought to ref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Hidetomo, Tokuda, Takahiko, El-Agnaf, Omar M. A., Ohmichi, Takuma, Miki, Ayako, Ohashi, Hideaki, Owan, Yoshiyuki, Saito, Yu, Yano, Satoshi, Tsukie, Tamao, Ikeuchi, Takeshi, Ono, Kenjiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549316/ https://www.ncbi.nlm.nih.gov/pubmed/31164098 http://dx.doi.org/10.1186/s12883-019-1346-y

Ejemplares similares

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
por: Murakami, Hidetomo, et al.
Publicado: (2018)

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
por: Kasuga, Kensaku, et al.
Publicado: (2022)

Mini Review: Correlations of Cognitive Domains With Cerebrospinal Fluid α-Synuclein Levels in Patients With Parkinson's Disease
por: Murakami, Hidetomo, et al.
Publicado: (2021)

Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
por: Kakuda, Keita, et al.
Publicado: (2019)

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
por: Ishii, Ryotaro, et al.
Publicado: (2015)

Longitudinal clinical and neuro-radiological findings in a patient with leukoencephalopathy with brain calcifications and cysts (Labrune syndrome)()
por: Iwasaki, Yasushi, et al.
Publicado: (2017)

Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting
por: Kinno, Ryuta, et al.
Publicado: (2017)

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)

Effects of an essential amino acid mixture on behavioral and psychological symptoms of dementia and executive function in patients with Alzheimer's disease: A double‐blind, randomized, placebo‐controlled exploratory clinical trial
por: Takada, Michihiro, et al.
Publicado: (2022)

Cerebral white matter lesions and regional blood flow are associated with reduced cognitive function in early-stage cognitive impairment
por: Kuroda, Takeshi, et al.
Publicado: (2023)

Increased Presence of Cerebral Microbleeds Correlates With Ventricular Enlargement and Increased White Matter Hyperintensities in Alzheimer’s Disease
por: Kuroda, Takeshi, et al.
Publicado: (2020)

Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy
por: Mori, Yukiko, et al.
Publicado: (2021)

Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016)

Nonsystemic vasculitic neuropathy in a patient with IgG-monoclonal gammopathy of undetermined significance: A case report
por: Kinno, Ryuta, et al.
Publicado: (2020)

Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation
por: Ikeuchi, Takeshi, et al.
Publicado: (2011)

The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer’s disease
por: Nomoto, Shohei, et al.
Publicado: (2019)

The subjective perception of past, present, and future time in patients with Alzheimer’s disease: a qualitative study
por: Shiromaru-Sugimoto, Azusa, et al.
Publicado: (2018)

Recurrent HyperCKemia with Immunological Involvement of the Endomysial Capillaries in Neuromyelitis Optica
por: Kinno, Ryuta, et al.
Publicado: (2020)

High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population
por: Kinno, Ryuta, et al.
Publicado: (2019)

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
por: Tatebe, Harutsugu, et al.
Publicado: (2017)

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)

Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021)

Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus
por: Nakajima, Madoka, et al.
Publicado: (2018)

Neuroprotective Potential of Raloxifene via G-Protein-Coupled Estrogen Receptors in Aβ-Oligomer-Induced Neuronal Injury
por: Nohara, Tetsuhito, et al.
Publicado: (2023)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Agraphia of the left hand with dysfunction of the left superior parietal region without callosal lesions
por: Kinno, Ryuta, et al.
Publicado: (2018)

Sex Differences in the Relationship of Serum Vitamin B1 and B12 to Dementia Among Memory Clinic Outpatients in Japan
por: Miki, Ayako, et al.
Publicado: (2021)

Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019)

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019)

Transferrin isoforms in cerebrospinal fluid and their relation to neurological diseases
por: MURAKAMI, Yuta, et al.
Publicado: (2019)

Combined Treatment with Curcumin and Ferulic Acid Suppressed the Aβ-Induced Neurotoxicity More than Curcumin and Ferulic Acid Alone
por: Ohashi, Hideaki, et al.
Publicado: (2022)

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
por: Constantinides, Vasilios C., et al.
Publicado: (2021)

Increased levels of plasma total tau in adult Down syndrome
por: Kasai, Takashi, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)

Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA
por: Iannuzzi, Francesca, et al.
Publicado: (2014)

Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
por: Straeten, Frederike, et al.
Publicado: (2022)

The Curcumin Derivative GT863 Protects Cell Membranes in Cytotoxicity by Aβ Oligomers
por: Momma, Yutaro, et al.
Publicado: (2023)

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
por: Hashimoto, Kenji, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_o114fg552d9qgn02c5d3gj0gm0